logo
Bell County Emergency Management assessing storm damage

Bell County Emergency Management assessing storm damage

Yahoo27-05-2025

BELL COUNTY, Texas (FOX 44) – The Bell County Office of Emergency Management (OEM) is assessing damage from two rounds of severe storms.
According to county, these storms occured on Monday, May 26. These resulted in power outages, structural damage, and debris-covered roadways. The first round began around 7 a.m., followed by a second round around 8 p.m.
Bell County Emergency Management (OEM), along with Bell County Road and Bridge and the Texas Department of Transportation, worked through the night to clear debris from roadways. The county says storms moved from west to east, producing heavy rainfall, damaging winds, and some hail. Wind gusts reached 80 to 85 miles per hour, knocking over trees and power lines and damaging homes and outbuildings.
The county says no tornadoes have been confirmed. The Office of Emergency Management has not received any reports of major injuries. ONCOR crews are working to restore power as quickly and safely as possible. However, the county says this process may take time due to numerous downed power poles and lines.
Property owners who sustained damage are encouraged to report it through the Texas Division of Emergency Management's (TDEM) Individual State of Texas Assessment Tool (iSTAT). The county says this tool allows people to report damage to private homes and businesses, helping emergency officials assess the extent of the impact.
If you need to report storm damage, you can visit the TDEM iSTAT website or scan the QR code below. Select the survey titled 'May 18th – Ongoing Severe Weather.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Canada approves Abbott's i-STAT TBI test for suspected concussions
Health Canada approves Abbott's i-STAT TBI test for suspected concussions

Yahoo

time4 days ago

  • Yahoo

Health Canada approves Abbott's i-STAT TBI test for suspected concussions

Health Canada has granted approval for Abbott's i-STAT TBI test cartridge, enabling clinicians to evaluate suspected concussions more effectively. The authorisation allows for the use of the test cartridge with whole blood, enabling clinicians to get lab-quality results in 15 minutes. Previously, mild traumatic brain injury (mTBI) assessment tests were authorised only for plasma or serum samples, necessitating lab processing. The approval facilitates testing in diverse healthcare settings, potentially expanding to pharmacies, clinics without radiology, and even sporting event sidelines. The i-STAT TBI test is designed to assess those who are 18 years and above with suspected mTBI (commonly referred to as concussion). It can help rule out the requirement for a head computed tomography (CT) scan and guide the further steps for individual care, using other clinical information. The authorisation also extends the test's utility to assess individuals up to 24 hours post-injury, addressing situations where individuals may delay seeking medical attention. Abbott's market offerings for TBI testing already include the i-STAT TBI Plasma test and the ARCHITECT and Alinity i lab tests for serum and plasma. To be used with the i-STAT Alinity System, the i-STAT TBI test cartridge needs only a small blood sample. It measures two brain-specific biomarkers, ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP), released into the bloodstream after brain injury. If levels of these biomarkers are below a certain threshold, a serious injury is unlikely, and a CT scan may be avoided. Abbott diagnostics business senior medical director Beth McQuiston said: "We're proud of this important step forward in advancing the standard of care for concussions. 'With this approval, right from the patient's bedside, clinicians are now able to order a rapid blood test that can provide powerful objective information, quickly. This dramatically changes the efficiency in the emergency room and helps optimise patient care." In April 2025, the company reported new data from its Volt CE Mark Study, indicating that individuals treated with pulsed field ablation (PFA) therapy using the Volt PFA System for atrial fibrillation (AFib) showed efficacy and safety up to 12 months. "Health Canada approves Abbott's i-STAT TBI test for suspected concussions" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions

Yahoo

time5 days ago

  • Yahoo

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions

The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), otherwise known as concussion The test produces lab-quality results in 15 minutes Clinicians can get a result at the patient's bedside, making the test accessible at urgent care clinics and healthcare settings outside of the hospital emergency room The test can be used to help evaluate patients up to 24 hours after injury MISSISSAUGA, ON, June 16, 2025 /CNW/ -- Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes. Previously, the tests used to help assess mild traumatic brain injury (mTBI) were only authorized for use with plasma or serum, requiring samples to be sent to a lab for processing. This new authorization will enable testing to be performed in an array of new healthcare settings beyond hospital emergency departments, including urgent care clinics. This is an important step toward a future where testing could be done in settings such as in pharmacies, clinics without radiology or even in locations such as the sidelines of a sporting event. "Particularly in the emergency setting, we have long needed a reliable and expedient way to assess and triage patients for urgent computed tomography (CT) imaging of the brain after head trauma," said Andrew Beckett, M.D., a trauma surgeon and medical director of the Trauma Program at St. Michael's Hospital, Unity Health Toronto, and an associate professor at the University of Toronto. "The availability of a rapid point of care and objective test for traumatic brain injury will be a major advancement in emergency care as it can help facilitate immediate and precise diagnosis, ensuring prompt, appropriate treatment." The whole blood test on a portable instrument helps clinicians evaluate patients 18 years of age and older who present with suspected mTBI, commonly known as a concussion. Test results can help rule out the need for a CT scan of the head and assist in determining the best next steps for patient care in conjunction with other clinical information. The ability to perform the test with a whole blood sample means testing can take place in healthcare settings without a lab, which helps to accelerate head trauma evaluation. With this authorization, the i-STAT TBI test cartridge can be used to help evaluate patients up to 24 hours after injury, an important advancement since those injured often wait to seek care. It is estimated that 165,000 Canadians will experience a TBI this year.1 Likewise, each year in Canada, more than 20,000 people are hospitalized for TBI, which can range from mild to severe and include concussions.2 Among all types of TBIs, concussions are the most common, accounting for approximately 80 to 95 percent of such injuries.3 Even a mild form of TBI can have long-term consequences.2 For decades, standard TBI assessment has remained the same, with doctors leveraging tools such as the Canadian CT Head Rule which uses the Glasgow Coma Scale, a subjective assessment as well as CT scans, to detect brain tissue damage or lesions. A blood test provides objective information and helps remove the ambiguity of a standard concussion assessment. "Abbott has pioneered breakthroughs in TBI testing technology for more than a decade," said Beth McQuiston, M.D., senior medical director in Abbott's diagnostics business. "We're proud of this important step forward in advancing the standard of care for concussions. With this approval, right from the patient's bedside, clinicians are now able to order a rapid blood test that can provide powerful objective information, quickly. This dramatically changes the efficiency in the emergency room and helps optimize patient care." This approval expands Abbott's TBI test on market offerings, which already includes the i-STAT TBI Plasma test and the ARCHITECT® and Alinity i lab test (serum and plasma). How the test works: The i-STAT TBI test cartridge with the i-STAT Alinity System requires a small venous blood sample – just a few drops applied to the test cartridge. The cartridge is then inserted into the portable i-STAT Alinity instrument. The test measures two brain-specific biomarkers that are released into the blood stream when there is a significant brain injury. If neither of these biomarkers measured are above an established cutoff, a significant injury has likely not occurred, and a CT scan can likely be avoided. Testing for these two biomarkers – ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) – following an injury can provide essential and objective information about a patient's condition and can help healthcare providers decide an appropriate treatment plan. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at and on LinkedIn, Facebook, Instagram, X and YouTube. The i-STAT TBI test cartridge was developed with support by the U.S. Department of Defense U.S. Army Medical Research and Development Command's (USAMRDC) U.S. Army Medical Materiel Development Activity (USAMMDA). The USAMRDC has been dedicated to developing a solution for the objective detection and evaluation of TBI for more than two decades and has played a critical role in developing the TBI test on Abbott's i-STAT Alinity platform. (Reference to USAMRDC and USAMMDA does not imply or constitute endorsement by these organizations or by the Department of Defense or the U.S. Army.) The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team was the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care. References 1 Brain Injury Canada. Statistics: Traumatic brain injury (TBI) general statistics. Available at Accessed on April 29, 2025.2 Government of Canada. Injury in review, 2020 edition: Spotlight on traumatic brain injuries across the life course. Available at Accessed November 2024.3 Statistics Canada. Self-reported concussions in Canada: A cross-sectional study. Available at Accessed November 2024. SOURCE Abbott View original content to download multimedia: Sign in to access your portfolio

Army Marks 250 Years of Service and Sacrifice
Army Marks 250 Years of Service and Sacrifice

Yahoo

time14-06-2025

  • Yahoo

Army Marks 250 Years of Service and Sacrifice

Hewitt, TX (FOX 44) – The U.S. Army is celebrating its 250th birthday on Saturday, marking a quarter-millennium of service since its founding in 1775. The milestone honors the Army's legacy of defending the nation, supporting allies, and leading in innovation, strength, and resilience. The VFW in Hewitt is celebrating at 9 a.m. Saturday, starting with a Flag Day Ceremony where all military flags will be raised. 'At 4 p.m., we're going to start kicking off our Army birthday,' Executive Assistant to Commander Sean Escarciga said. 'So that's going to be cake, food. We're gonna have a fish fry at 7:30. Chicken tenders….if you're not into fish fry, we're going have a band – the Heart of Texas band.' Celebrations across the country will include ceremonies, parades, historical exhibits, and community events recognizing the service and sacrifice of soldiers past and present. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store